Research Topics
| Inge van RossumSummaryAffiliation: Eli Lilly and Company Country: USA Publications
|
Detail Information
Publications
[The influence of cannabis on the course of bipolar disorder: a longitudinal analysis]I Winter-van Rossum
Lilly Nederland B V, Houten
Tijdschr Psychiatr 52:287-98. 2010..Research shows that the use of cannabis has a negative impact on the onset and outcome of schizophrenia, but little is known about possible effects on mood disorders...
Bipolar disorder and dopamine dysfunction: an indirect approach focusing on tardive movement syndromes in a naturalistic settingInge van Rossum
Eli Lilly Nederland, Medical Department, Houten, The Netherlands
BMC Psychiatry 9:16. 2009..An indirect approach to examine this issue was developed, focusing on associations between dopamine proxy measures observed in BD (dopamine-related clinical traits using tardive movement syndromes as dopamine proxy measure of reference)...
Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysisInge van Rossum
Medical Department, Eli Lilly Nederland, Houten, The Netherlands
J Nerv Ment Dis 197:35-40. 2009..An independent impact of cannabis use on psychopathologic outcomes in patients with bipolar disorder was apparent, whereas the impact on social outcomes was modest...
Stability and treatment outcome of distinct classes of maniaInge van Rossum
Medical Department, Eli Lilly Nederland, Grootslag 1 5, Houten, The Netherlands
Eur Psychiatry 23:360-7. 2008..Differential treatment course and outcome after 12 weeks of treatment were examined for three distinct classes of patients with acute mania in bipolar disorder...
